These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9216197)
1. [A new strategy for treating small cell lung cancer]. Ueda R; Takashi T Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956 [TBL] [Abstract][Full Text] [Related]
3. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Krystal GW; Hines SJ; Organ CP Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594 [TBL] [Abstract][Full Text] [Related]
4. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer. Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596 [TBL] [Abstract][Full Text] [Related]
5. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Hibi K; Takahashi T; Sekido Y; Ueda R; Hida T; Ariyoshi Y; Takagi H; Takahashi T Oncogene; 1991 Dec; 6(12):2291-6. PubMed ID: 1722571 [TBL] [Abstract][Full Text] [Related]
6. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells. Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836 [TBL] [Abstract][Full Text] [Related]
7. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933 [TBL] [Abstract][Full Text] [Related]
8. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946 [TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer. Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of small cell lung carcinoma. Wistuba II; Gazdar AF; Minna JD Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891 [TBL] [Abstract][Full Text] [Related]
11. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1. Krystal GW; DeBerry CS; Linnekin D; Litz J Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619 [TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial. Krug LM; Crapanzano JP; Azzoli CG; Miller VA; Rizvi N; Gomez J; Kris MG; Pizzo B; Tyson L; Dunne M; Heelan RT Cancer; 2005 May; 103(10):2128-31. PubMed ID: 15812822 [TBL] [Abstract][Full Text] [Related]
13. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468 [TBL] [Abstract][Full Text] [Related]
14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339 [TBL] [Abstract][Full Text] [Related]
15. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer. Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051 [TBL] [Abstract][Full Text] [Related]
16. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814 [TBL] [Abstract][Full Text] [Related]
17. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis. Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786 [TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling. Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339 [TBL] [Abstract][Full Text] [Related]
19. Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969 [TBL] [Abstract][Full Text] [Related]
20. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]